The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics. WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version. The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal. WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%. |
Profile: President of Suriname Chandrikapersad SantokhiMultiple indicators signal upward trend in Chinese economyMOC criticizes US' move against Chinese companiesComicomment: NATO at 75, what's next?Chile recalls ambassador to Venezuela for consultationsXinhua Commentary: Who is posing a dire threat to the global economy?China's new factory data evidence of good momentum in its economy: FM spokespersonMexico formally denounces Ecuador to ICJ for embassy raidEcuador calls OAS resolution on Mexican embassy raid "fair"Emission capping in focus as scientists predict hotter 2024